Overview

It is challenging to keep up with newly FDA-approved drugs and to learn which ones may have an important role in primary care. In this lecture, Dr. Smetana will provide balanced evidence on several newly approved drugs. You will learn which ones may change your practice and how new drugs compare with existing therapies in terms of efficacy and safety profile.

Learning Objectives

  • Understand which newly approved drugs are relevant to primary care practice
  • Apply knowledge regarding the efficacy and safety of new drugs
  • Compare new drugs to existing drugs for similar indications
  • Understand how cost may affect uptake of new medications.